Michael Jonas

Diabetes and Cardiovascular Disease

A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitochondria-Derived Reactive Oxygen Species Mediate Heme Oxygenase-1 Expression in Sheared Endothelial Cells

Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Mechanisms of Thrombus Formation

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis

Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?

Postinfarction Use of β-Blockers in Elderly Patients

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Pathology of Drug-Eluting Stents in Humans

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

Uric Acid and Cardiovascular Risk

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

The changing landscape of atherosclerosis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

Antioxidants and Atherosclerotic Heart Disease

Platelet Activation and Atherothrombosis

Inappropriate Drug Prescribing in Home-Dwelling, Elderly Patients

Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release

T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis

Type 2 diabetes

Diabetes and Atherosclerosis

Myocarditis

The pathophysiology of cigarette smoking and cardiovascular disease

Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients

Atherosclerosis

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention

Third Universal Definition of Myocardial Infarction

Inflammation, Atherosclerosis, and Coronary Artery Disease

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications

Cancer-related inflammation

Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association

Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium.

Monocytes in atherosclerosis: subsets and functions

Intensive Insulin Therapy in the Medical ICU

In-Stent Restenosis in the Drug-Eluting Stent Era

The Tumor Necrosis Factor Ligand and Receptor Families

Myocarditis

Management of Diabetes and Hyperglycemia in Hospitals

Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

The Inflammatory Preatherosclerotic Remodeling Induced by Intermittent Hypoxia Is Attenuated by RANTES/CCL5 Inhibition

A review of the epidemiological evidence for the ‘antioxidant hypothesis’

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

Cardioselective beta-blockers for chronic obstructive pulmonary disease

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer

Clinical End Points in Coronary Stent Trials

Coronary Plaque Disruption

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

Large Scale Cohort Study of the Relationship Between Serum Cholesterol Concentration and Coronary Events With Low-Dose Simvastatin Therapy in Japanese Patients With Hypercholesterolemia. Primary Prevention Cohort Study of the Japan Lipid Intervention Trial (J-LIT).

Phospholipase A₂Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

Cigarette Smoking, Cardiovascular Disease, and Stroke

Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly

Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques

Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling

Sulfonylureas Are Not Associated With Increased Mortality in Diabetics Treated With Thrombolysis for Acute Myocardial Infarction

Comparison of early invasive and conservative treatments in patients with anterior wall non-Q-wave acute myocardial infarction

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease

Long-term diuretic therapy in patients with coronary disease: increased colon cancer-related mortality over a 5-year follow-up

Risk stratification of individual coronary lesions using local endothelial shear stress: a new paradigm for managing coronary artery disease

The PROXIMAL Trial: Proximal Protection During Saphenous Vein Graft Intervention Using the Proxis Embolic Protection System

Antioxidants and cardiovascular disease: a review.

Is immunosuppressive treatment an option for myocarditis?

Statement on smoking and cardiovascular disease for health care professionals. American Heart Association.

Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting Stents